Accelerate Diagnostics Stock (NASDAQ: AXDX) stock price, news, charts, stock research, profile.
Open | $1.000 |
Close | $0.990 |
Volume / Avg. | 86.630K / 125.220K |
Day Range | 0.980 - 1.050 |
52 Wk Range | 0.833 - 11.900 |
Market Cap | $20.235M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 1.88% |
Days to Cover | 3.82 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Accelerate Diagnostics (NASDAQ: AXDX) through any online brokerage.
Other companies in Accelerate Diagnostics’s space includes: Precision Optics Corp (NASDAQ:POCI), ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Talis Biomedical (NASDAQ:TLIS) and QT Imaging Holdings (NASDAQ:QTI).
The latest price target for Accelerate Diagnostics (NASDAQ: AXDX) was reported by Craig-Hallum on Wednesday, March 9, 2022. The analyst firm set a price target for 5.00 expecting AXDX to rise to within 12 months (a possible 426.32% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Accelerate Diagnostics (NASDAQ: AXDX) is $0.95 last updated March 28, 2024 at 4:05 PM EDT.
There are no upcoming dividends for Accelerate Diagnostics.
Accelerate Diagnostics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Accelerate Diagnostics.
Accelerate Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.